Metraipolis › archive › dc_613daf6b4fe5
Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41877774
- DOI
- 10.3389/fmed.2026.1771320
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T00:28:57.761Z
- SHA-256 of the archived text
a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e- Stable URL of this page
https://metraipolis.com/documento/dc_613daf6b4fe5
How to cite
Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774 — Europe PMC (en), https://europepmc.org/article/MED/41877774 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_613daf6b4fe5 (Metraipolis archive dc_613daf6b4fe5, sha256 a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e)
BibTeX
@misc{dc613daf6b4fe5,
title = {Individualizing isotretinoin dosing in acne: comparable 24-week efficacy and better tolerability at lower daily doses — Europe PMC PMID:41877774},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41877774},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_613daf6b4fe5; sha256 a891d3365ba6dff7e9850da11c3820d2c9e22712193cd0859f5269652e81926e},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41877774. Agents can read the archived copy with the MCP tool read_document.